Biotron Limited ( (AU:BIT) ) has shared an update.
Biotron Limited has announced the dispatch of documents related to its rights issue, which was initially declared on February 28, 2025. The rights issue aims to raise approximately $2.7 million by offering around 902 million new shares at $0.003 each to eligible shareholders in Australia and New Zealand. The offer is open until April 1, 2025, and aims to strengthen the company’s financial position, potentially impacting its market operations and stakeholder interests.
More about Biotron Limited
Biotron Limited is a company listed on the Australian Securities Exchange (ASX: BIT), operating in the biotechnology industry. The company focuses on developing and commercializing innovative therapeutics, primarily targeting viral diseases.
YTD Price Performance: 390.0%
Average Trading Volume: 35,666
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $4M
Find detailed analytics on BIT stock on TipRanks’ Stock Analysis page.